This is an overview concerning nuances of the animal models that are used to study the diseases that cause erectile dysfunction.
Background
What are the diseases that cause erectile dysfunction in men that can be studied in animal models? The list includes diabetes mellitus, hypertension and the effect of drugs used to treat hypertension, arteriosclerosis, hyperprolactinemia, alcoholism, renal failure, smoking, radiation-induced injury, and neural and spinal cord injury.
A literature search shows that the disease that has been studied the most in animal models as a marker for erectile dysfunction has been diabetes mellitus. Because the largest published experience has been the study of diabetes mellitus in the rat animal model, I would like to concentrate on that experience. The classical method of creating diabetes in an animal model is with the use of streptozotocin (STZ), which can be administered subcutaneously, intraperitoneally, or intravenously with doses ranging from 35 to 75 mgakg. It is important, in either planning the experiments or interpreting the data, that one is cognizant of the strain of rat used. The reason is that the strain of animal may vary the response of the drug or the effect of the diabetes on the animal. An important aspect of interpreting a published paper to evaluate a study is clearly taking note of the strain of rat used as well as the dose and the method of delivery of the medication. The age of the animal must also be noted so that comparison with other studies can be fairly made.
The predominant effect of STZ in rats is to cause a neuropathic abnormality as a creation of the erectile dysfunction. The neuropathy is the cause of the erectile failure. 1 It is also true that with time, in animals that are going to survive the STZ, they may actually improve and return to normalcy, if they survive long enough.
In a study with Ben Sachs, published in 1982, we studied erectile and endocrine function of STZ rats 1 y after the induction of diabetes. 2 Our conclusion was that there was not any effect of diabetes. However, the only animals we studied were those who had survived and recovered from the disease. The parameters of interest had all returned to normal levels. Therefore, because of that possibility, when reviewing a paper one wants to know the duration of the disease at the time that the study is done.
Other ways of creating diabetes
Subtotal pancreatectomy (7a8's pancreatectomy) Ð is a very effective way of creating the animal model, but the induction of disease is more dif®cult than STZ injection because a surgical procedure is needed and there is a greater loss of animal life in creating the model than occurs with STZ injection. 3, 4 Subtotal pancreatectomy-induced diabetes, as with STZ-induced disease, causes hyperglycemia and a profound neuropathy. Unlike the STZinduced diabetes, there is no loss of the effect with time, as there is no regrowth of the pancreas. It is a very effective model to use in rats.
If one wants to study the effects of diabetes on erectile function in rabbits, the drug alloxan may be given to induce the diabetes. However, alloxaninduced disease causes severe dehydration that may result in morbidity and death of a high percentage of the rabbits. There have not been studies published on erectile function (penile rigidity, copulation and penile re¯exes) in the conscious rabbit as compared with the well-characterized rat animal model using STZ that has literally had hundreds of published studies. 5 However, at the present meeting Bischoff presented a new animal model in conscious rabbits in which the effects of Vardena®l on penile erection have been studied. 6 This report will de®nitely enhance the use of rabbits as animal models of erectile dysfunction.
There are several genetic models of diabetes in rats. The BBZaWOR is a non insulin-dependent form of diabetes, and the BBaWOR is an insulindependent diabetic animal model that occurs spontaneously. 7, 8 The problem with the latter is that there is less neuropathy induced than with the STZ model. Therefore, it is not as good a model for studying the effects of neuropathic-induced diabetic changes in erectile dysfunction.
In the rat, one could also study penile re¯exes and copulatory effects of the diabetes. The effects of the diabetes are manageable by replacing water and giving insulin as an additional control if the hypoglycemia were too severe.
In the current atmosphere that includes a resurgent interest in the effects of disease upon female sexual dysfunction, it is of interest that an excellent paper was on the program at this meeting by Giraldi, in which STZ-induced diabetes was studied in a female animal model. 9 In that study, the diabetesinduced changes in vaginal smooth muscle were similar to the effects on smooth muscle in the male. She also evaluated the effect of the menstrual and hormonal cycle on the tissues of interest Ð a very important aspect of the study because STZ-induced diabetes does affect hormonal regulation in the animal.
Because both diabetes and aging cause degeneration of the nitrenergic neurons of the penis, there may be a reduction in both the smooth muscle and endothelial cells of the penis. 10 It is important to know the age of the animals and the region of the penis that is being studied, to ensure that the studies are comparable Ð whether or not the needle used to measure pressure is placed in the crura, or placed at the body or distal end of the penis in the region of the os penis. Similarly, if histological studies are done to allow comparison with other studies it is critical to know from what region of the penis the histological sections are being removed. It is clear from reading the literature that the histological evaluation of the penis records results from tissue taken from all of the available locations. Both the histological architecture and the response to drugs may vary from region to region within the penis.
In the rat, the region that is most physiologically relevant to the human studies is the proximal portion of the crura.
Both libido and erection are very sensitive to reduction of testosterone in the rat. Diabetes induced by STZ or with subtotal pancreatectomy will cause a reduction in plasma testosterone levels. It is important also that these be measured in the study to know that the effect one is measuring is not a reduction from change in testosterone (and not just the induction of diabetes by the drug). It has also been shown, by Julian Davidson and his group, that replacement of testosterone to only one-third of the normal level will allow return of normal erectile function (sexual behavior) in the rat. 11 Large reductions in plasma testosterone levels may occur, but normal re¯exes, even in the presence of diabetes, may prevail.
It has been shown that high cholesterol and high triglyceride diets can cause atherosclerosis and erectile dysfunction in both the rat and the rabbit. There is an increasing utilization of these dietary tools, to study the effect of diet and atherosclerosis as a way of studying erectile dysfunction. 12, 13 Similarly, the effect of antihypertensive drugs on erectile function can be studied in animal models and the results of the least deleterious drug transferred to human therapy. 14 There have been very few reports in the literature studying the effects of hyperprolactinemia; therefore, we embarked on such a study in our laboratory. The results were published earlier this year. 15 There has been some controversy about what the actual effects of hyperprolactinemia are: whether they are central or penile effects. We created a hyperprolactinemic model in the rat by injecting prolactin. We concluded that the effect was central. By subjecting the animals to either papaverine injection into the penis or cavernous nerve stimulation, the animals were capable of absolutely normal erections. This ®nding con®rms an earlier report and opens a potentially fertile ®eld for future study to identify the effect of hyperprolactinemia in the brain and to describe the mechanism of action. 16 The recent introduction of apomorphine as a possible treatment for human erectile dysfunction has caused a recrudescence in the use of penile re¯exes and copulatory studies in the rat animal model of erectile dysfunction. 17 The animal model can be utilized for studies of the effect of combinations of drugs and other centrally acting agents as well prior to human trials. 18, 19 It is interesting that although smoking is such a prevalent cause of disease throughout the world, there have been only a few reports of studies on the effect of smoking on penile physiology. One report, in the rat, had equivocal results in that there was some increase in the mean arterial pressure (115 vs 162 mmHg in 5-month-old rats and 113 vs 140 mmHg in 20-month-old rats), caused by passive smoking. 20 The studies were done in young (5-month-old) and old (20-month-old) rats. In other parts of their study, they showed that there was a reduction in nNOS, but not in eNOS, and there was no change in NO release, as induced by electrical stimulation in this model; so their conclusions were somewhat limited. It must be understood that 20-month-old rats, as a result of aging, will have erectile dysfunction. Companies that sell retired breeder rats do so at a lower price than for younger rats, because they have erectile dysfunction and cannot breed. Thus, the old rats have erectile dysfunction as a result of aging.
Pathophysiologic basis of erectile dysfunction A Melman
In another report in which dogs were studied, ie dogs that were subjected to passive inhalation of smoke from 2 ± 3 cigarettes, there was an acute decrease in their internal pudendal¯ow, and a decrease in their ability to trap blood in the penis (decreased veno-occlusion), so that ®ve out of six dogs were unable to achieve full erection. 21 One of the problems in employing the dog as a large animal model, as opposed to rodent research, is a consequence of the lobbying of the animal rights groups. Dogs studied in academic centers must be raised speci®cally for scienti®c purposes and become very expensive, making it almost impossible to utilize them.
Spinal cord (SCI) and neurological injury and their effect of erectile dysfunction in animal models have been infrequently studied. One report showed basically that SCI resembled the human condition in that in spinal cord-injured rats, there was an increased sensitivity to intracavernosal papaverine, intraurethral nitroglycerine, and to minoxidil. 22 Other reports on neurologic injury show the histologic and morphologic effects on the rat penis. 23, 24 Other important diseases and therapies that can and have been studied in animal models include chronic alcoholism, renal failure, and the effects of radiation on erectile function. 25 ± 27 
Conclusion
In summary, animal models can be selectively used to study many of the diseases and therapies that cause erectile and sexual dysfunction in humans. The rat is the most useful of the experimental animals for those studies, as it satis®es most of the criteria for the study of many of the human diseases. However, as the ®eld expands and more speci®c questions need to be answered, any animal model, if its limitations are known, can be chosen to solve the speci®c problem. In the future, as our technology improves, the knockout mouse with speci®c genetic changes will be so employed.
